ImmunoCAP Rapid
Fast Answers for Fast Action

These products may not be cleared for use in your country. Please contact your sales representative for information about specific product availability.

Specific IgE Point-of-Care

ImmunoCAP™ Rapid™ is a quick and user-friendly point-of-care test to be performed in near-patient healthcare settings such as doctors’ offices and nurse stations to rule in or rule out allergy.1,2 It identifies 92 to 95 percent of symptomatic patients sensitized to any of the included allergens.3,4

 


 

There are three different test panels available, each holding a fixed set of 10 different allergens.*

 

ImmunoCAP Rapid
Wheeze/Rhinitis Child

Cat

Birch

Mugwort

Timothy

Egg White

Dog 

Olive pollen

Wall pellitory

House dust mite

Cow's milk

ImmunoCAP Rapid
Asthma/Rhinitis Adult

Cat

Birch

Mugwort

Timothy

Cockroach

Dog

Olive

Wall pellitory

House dust mite

Mold

ImmunoCAP Rapid
Rhinitis/Asthma 1*

Cat

Mold

Cocksfoot

Common ragweed

Mugwort

Dog

Cockroach

Japanese Cedar

 

 

*ImmunoCAP Rapid Rhinitis/Asthma 1 holds eight different allergens.

 


Single-use technology

ImmunoCAP Rapid is a single use, disposable testing device.

Broad application

The ImmunoCAP Rapid test can be performed irrespective of age, symptoms, disease activity, and antihistamine medication.

Easy and quick testing

ImmunoCAP Rapid is a specific IgE antibody blood test that will determine whether antibodies to any of the allergens included in the test are present in your patient’s blood. The test will provide a clear and reliable answer in 20 minutes while you wait.

Reliable results

You will receive proven and reliable results, with good concordance to ImmunoCAP Specific IgE blood tests.5

ImmunoCAP Rapid is available in dedicated European countries and in Japan.

Quickly rule in or rule out allergy

The test is a first-line evaluation tool that supports healthcare providers in the decision to rule in or rule out allergy.1,2

The test results should be interpreted in the context of the patient’s clinical history, before making a diagnosis. Regardless of the results, it is recommended that a symptomatic patient follow up with their healthcare provider.

ImmunoCAP Rapid Test Diagram
Explore the full ImmunoCAP portfolio.
View Portfolio
Find an instrument to run ImmunoCAP tests.
View Phadia Laboratory Systems
Get scientific information on whole allergens, allergen mixes, and allergen components.
Visit Allergen Encyclopedia
References
  1. Sarratud, T., et al., Accuracy of a point-of-care testing device in children with suspected respiratory allergy. Allergy Asthma Proc, 2010. 31(2): p. e11-7.
  2. Diaz-Vazquez, C., et al., Accuracy of ImmunoCAP Rapid in the diagnosis of allergic sensitization in children between 1 and 14 years with recurrent wheezing: the IReNE study. Pediatr Allergy Immunol, 2009. 20(6): p. 601-9.
  3. Hedlin, G., et al., Allergy Diagnosis in Children and Adults: Performance of a New Point-of-Care Device, ImmunoCAP Rapid. World Allergy Organ J, 2009. 2(7): p. 138-43.
  4. Eigenmann, P.A., et al., The ImmunoCAP Rapid Wheeze/Rhinitis Child test is useful in the initial allergy diagnosis of children with respiratory symptoms. Pediatr Allergy Immunol, 2009. 20(8): p. 772-9.
  5. Jan Forslid, P.M.L.S., Laboratory evaluation of a qualitative in vitro test for specific IgE in primary care as compared to quantitative measurement using automated ImmunoCAP FEIA processing. EAACI, 2008. Poster discussion 230.